HRP20030907B1 - Pharmaceutical composition based on macrolides for topical application in ophthalmology - Google Patents

Pharmaceutical composition based on macrolides for topical application in ophthalmology

Info

Publication number
HRP20030907B1
HRP20030907B1 HR20030907A HRP20030907A HRP20030907B1 HR P20030907 B1 HRP20030907 B1 HR P20030907B1 HR 20030907 A HR20030907 A HR 20030907A HR P20030907 A HRP20030907 A HR P20030907A HR P20030907 B1 HRP20030907 B1 HR P20030907B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical composition
topical application
macrolides
ophthalmology
composition based
Prior art date
Application number
HR20030907A
Other languages
English (en)
Croatian (hr)
Inventor
Luyckx Jacques
Pilotaz Fr�d�ric
Original Assignee
Laboratoires Thea
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Thea filed Critical Laboratoires Thea
Publication of HRP20030907A2 publication Critical patent/HRP20030907A2/hr
Publication of HRP20030907B1 publication Critical patent/HRP20030907B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HR20030907A 2001-04-12 2003-11-10 Pharmaceutical composition based on macrolides for topical application in ophthalmology HRP20030907B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0105114A FR2823441B1 (fr) 2001-04-12 2001-04-12 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
PCT/FR2002/001263 WO2002083178A1 (fr) 2001-04-12 2002-04-11 Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie

Publications (2)

Publication Number Publication Date
HRP20030907A2 HRP20030907A2 (en) 2004-02-29
HRP20030907B1 true HRP20030907B1 (en) 2010-04-30

Family

ID=8862340

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030907A HRP20030907B1 (en) 2001-04-12 2003-11-10 Pharmaceutical composition based on macrolides for topical application in ophthalmology

Country Status (31)

Country Link
US (1) US7064109B2 (el)
EP (1) EP1377316B1 (el)
JP (2) JP4558275B2 (el)
KR (1) KR100835002B1 (el)
CN (1) CN1496270B (el)
AR (1) AR034033A1 (el)
AT (1) ATE397460T1 (el)
BR (1) BRPI0208367B8 (el)
CA (1) CA2443728C (el)
CY (1) CY1108302T1 (el)
CZ (1) CZ300213B6 (el)
DE (1) DE60226962D1 (el)
DK (1) DK1377316T3 (el)
EA (1) EA008088B1 (el)
EG (1) EG23169A (el)
ES (1) ES2307754T3 (el)
FR (1) FR2823441B1 (el)
HK (1) HK1065708A1 (el)
HR (1) HRP20030907B1 (el)
HU (1) HU230459B1 (el)
MA (1) MA27005A1 (el)
MX (1) MXPA03009349A (el)
OA (1) OA12462A (el)
PA (1) PA8543401A1 (el)
PE (1) PE20021082A1 (el)
PL (1) PL204403B1 (el)
PT (1) PT1377316E (el)
SI (1) SI1377316T1 (el)
TN (1) TNSN03091A1 (el)
WO (1) WO2002083178A1 (el)
ZA (1) ZA200307718B (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
JPWO2007074904A1 (ja) * 2005-12-28 2009-06-04 わかもと製薬株式会社 水性医薬組成物
BRPI0808410A2 (pt) * 2007-02-28 2015-06-23 Aciex Therapeutics Inc Métodos e composições para normalizar secreções da glândula meibomiana
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
US8106111B2 (en) * 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
EP2394636B1 (en) * 2010-05-28 2014-03-19 Novagali Pharma S.A. Method for treating retinal conditions using an intraocular tamponade
US9044508B2 (en) * 2013-03-15 2015-06-02 Insite Vision Corporation Concentrated aqueous azalide formulations
JP7033789B2 (ja) * 2016-06-29 2022-03-11 オトノミー，インク． トリグリセリド耳用製剤とその使用
PT3266446T (pt) * 2016-07-07 2019-01-30 Salvat Lab Sa Composição oftálmica compreendendo óleo de rícino e triglicérido de cadeia média

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
EP0925789A1 (en) * 1997-12-02 1999-06-30 Pfizer Products Inc. Topical azithromycin compositions for the treatment of ocular infections
WO2000057866A2 (en) * 1999-03-31 2000-10-05 Insite Vision Incorporated Use of azalide antibiotics for the topical treatment or prevention of ocular infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6468328A (en) * 1987-09-09 1989-03-14 Suntory Ltd Anticorneoulcerative
JP2563336B2 (ja) * 1987-06-01 1996-12-11 エーザイ株式会社 角膜透過促進点眼剤
FR2746035B1 (fr) * 1996-03-15 1998-06-12 Microparticules de gel composite susceptibles d'etre utilisees comme vecteur(s) de principe(s) actif(s), l'un de leurs procedes de preparation et leurs applications
JP2000159659A (ja) * 1998-11-30 2000-06-13 Kazuo Tsubota 眼科用人工涙液

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1152644A (en) * 1966-07-01 1969-05-21 Abbott Lab Stable Solutions of Erythromycin Free Base
EP0925789A1 (en) * 1997-12-02 1999-06-30 Pfizer Products Inc. Topical azithromycin compositions for the treatment of ocular infections
WO2000057866A2 (en) * 1999-03-31 2000-10-05 Insite Vision Incorporated Use of azalide antibiotics for the topical treatment or prevention of ocular infections

Also Published As

Publication number Publication date
HUP0303864A3 (en) 2012-07-30
BRPI0208367B8 (pt) 2021-05-25
ATE397460T1 (de) 2008-06-15
JP2010043109A (ja) 2010-02-25
MA27005A1 (fr) 2004-12-20
ES2307754T3 (es) 2008-12-01
CN1496270A (zh) 2004-05-12
TNSN03091A1 (fr) 2005-12-23
PL204403B1 (pl) 2010-01-29
JP5170780B2 (ja) 2013-03-27
PL363538A1 (en) 2004-11-29
EA008088B1 (ru) 2007-02-27
SI1377316T1 (sl) 2008-10-31
EG23169A (en) 2004-06-30
JP4558275B2 (ja) 2010-10-06
ZA200307718B (en) 2004-09-02
MXPA03009349A (es) 2004-11-12
BR0208367B1 (pt) 2013-11-12
HUP0303864A2 (hu) 2004-03-01
WO2002083178A1 (fr) 2002-10-24
OA12462A (fr) 2006-06-24
PE20021082A1 (es) 2002-12-18
US7064109B2 (en) 2006-06-20
HU230459B1 (hu) 2016-07-28
PT1377316E (pt) 2008-09-15
CN1496270B (zh) 2010-05-26
AR034033A1 (es) 2004-01-21
FR2823441A1 (fr) 2002-10-18
JP2004526763A (ja) 2004-09-02
KR20030088466A (ko) 2003-11-19
CA2443728C (fr) 2011-01-04
EP1377316B1 (fr) 2008-06-04
DK1377316T3 (da) 2008-09-22
PA8543401A1 (es) 2003-01-24
EP1377316A1 (fr) 2004-01-07
FR2823441B1 (fr) 2004-09-10
CZ20032771A3 (cs) 2004-01-14
CA2443728A1 (fr) 2002-10-24
BR0208367A (pt) 2004-03-09
DE60226962D1 (de) 2008-07-17
CY1108302T1 (el) 2014-02-12
HRP20030907A2 (en) 2004-02-29
US20040197340A1 (en) 2004-10-07
EA200301108A1 (ru) 2004-04-29
HK1065708A1 (en) 2005-03-04
CZ300213B6 (cs) 2009-03-18
KR100835002B1 (ko) 2008-06-09

Similar Documents

Publication Publication Date Title
HRP20030907B1 (en) Pharmaceutical composition based on macrolides for topical application in ophthalmology
BR0209320A (pt) ésteres de uridina farmaceuticamente ativos
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
HRP20060278B1 (hr) 6-0-supstituirani ketolidi antibakterijskog djelovanja
DE60123277D1 (de) Makrolidantibiotika
HK1131048A1 (zh) 含有肉荳蔻酸異丙酯和兒茶素的藥物
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
EA200501098A1 (ru) Антибактериальные агенты
WO2003004509A3 (en) C12 modified erythromycin macrolides and ketolides having antibacterial activity
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
DK1392329T3 (da) Anvendelse af sulodexid til behandling af inflammatorisk tarmsygdom
BRPI0506493A (pt) combinações terapêuticas
TR200200436T2 (tr) Yeni makrolit antibiyotikler
NO20001439L (no) 3'-N-modifiserte 6-O-substituerte erytromycin ketolid- derivater med antibakteriell aktivitet
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
AR023807A1 (es) Un agente para tratar el ojo seco y el uso de un compuesto macrolido para preparar composiciones farmaceuticas para el tratamiento del ojo seco
ATE429925T1 (de) Methoden und pharmazeutische zusammensetzungen zur wundheilung
YU59201A (sh) Matrica koja se može direktno komprimovati, za kontrolisano oslobadjanje pojedinačnih dnevnih doza klaritromicina
BRPI0413413A (pt) feniloxazolidinonas de piperidino substituìdo tendo atividade antimicrobiana com eficácia in vivo melhorada
BRPI0411702A (pt) uso de ácido hialurÈnico para preparar composições para o tratamento de aftas da cavidade oral
BR9708929A (pt) Composto composição farmacêutica e processos para controlar uma infecção bacteriana em um mamífero e para preparar compostos de macrólidos
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
FI945412A0 (fi) Alkoholit kaliumkanavan avaajina ja virtsanpidätyskyvyttömyyden hoidossa
DE60139409D1 (de) Pharmazeutische zusammensetzungen die ein dibenzocyclooctanlignanderivat enthalten zur vorbeugung und behandlung neurodegenerativer erkrankungen

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190325

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200319

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210318

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20220411